Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1–positive endometrial cancer: Results from the KEYNOTE-028 study

Patrick A. Ott, Yung Jue Bang, Dominique Berton-Rigaud, Elena Elez, Michael J. Pishvaian, Hope S. Rugo, Igor Puzanov, Janice M. Mehnert, Kyaw L. Aung, Juanita Lopez, Marion Carrigan, Sanatan Saraf, Mei Chen, Jean Charles Soria

Research output: Contribution to journal › Article › peer-review

179 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1–positive endometrial cancer: Results from the KEYNOTE-028 study'. Together they form a unique fingerprint.

Medicine & Life Sciences